A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)
Clinical trial NCT03125902 · COMPLETED
Trial details
- NCT number
- NCT03125902
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-25
- Primary completion
- 2019-11-15
- Enrollment
- 653
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.